Bevacizumab Monoclonal Antibody from United States
Bevacizumab is a humanized monoclonal antibody that binds vascular endothelial growth factor (VEGF) and is used to treat colorectal and lung cancers. This bulk, unmixed product is not in measured doses or retail packaging, making it classifiable under tariff item 3002.13.00 as an immunological product.
Duty Rate — United States → Canada
0%
Import Tips
• Ensure the shipment is labeled as a bulk pharmaceutical ingredient, not a finished drug product
• Provide a detailed product specification sheet to CBSA demonstrating the absence of measured doses or retail packaging
• Verify whether a Canadian importer's permit is needed under the Food and Drug Regulations